The fourth quarter is seasonally weak for ALKEM, and 4QFY17 was no different. The top-line grew by a mere 9.5% YoY, affected by channel de-stocking and seasonality. EBITDA margin at 11.9% and PAT at ~1.4bn also missed our estimates by ~370bps and 16% respectively.